Clinical Trial Update: ACTION - Anticoagulation Treatment Influence on Post-operative Patients [Phase 4]

View source ↗

Summary

The ACTION Phase 4 trial evaluating anticoagulation treatment in post-operative patients with valvular heart disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Valvular Heart Disease

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Valve Disease | Phase 4 | Status: WITHDRAWN